{"pmid":32277555,"title":"Novel Coronavirus (SARS-CoV-2) Infection in A Renal Transplant Recipient: Case Report.","text":["Novel Coronavirus (SARS-CoV-2) Infection in A Renal Transplant Recipient: Case Report.","An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infection to acute respiratory distress syndrome and acute renal failureno pharmacological therapies of proven efficacy yet exist. We report a case of SARS-CoV-2 infection in a renal transplant recipient with excellent outcome. This case states the importance of close monitoring of the concentration of ciclosporin in patients treated with lopinavir/ritonavir, routine treatment of corticosteroid can be continued. This is a rare report of SARS-CoV-2 infection in a renal transplant recipient. Further data are needed to achieve better understanding of the impact of immunosuppressive therapy on the clinical presentation, severity and outcome of SARS-CoV-2 infections in solid organ transplant recipients.","Am J Transplant","Ning, Ling","Liu, Lei","Li, Wenyuan","Liu, Hongtao","Wang, Jizhou","Yao, Ziqin","Zhang, Shengyu","Zhao, Desheng","Nashan, Bjorn","Shen, Aizong","Liu, Lianxin","Li, Lei","32277555"],"abstract":["An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in Wuhan, China, with cases now confirmed in multiple countries. The clinical course of patients remains to be fully characterized, clinical presentation ranges from asymptomatic infection to acute respiratory distress syndrome and acute renal failureno pharmacological therapies of proven efficacy yet exist. We report a case of SARS-CoV-2 infection in a renal transplant recipient with excellent outcome. This case states the importance of close monitoring of the concentration of ciclosporin in patients treated with lopinavir/ritonavir, routine treatment of corticosteroid can be continued. This is a rare report of SARS-CoV-2 infection in a renal transplant recipient. Further data are needed to achieve better understanding of the impact of immunosuppressive therapy on the clinical presentation, severity and outcome of SARS-CoV-2 infections in solid organ transplant recipients."],"journal":"Am J Transplant","authors":["Ning, Ling","Liu, Lei","Li, Wenyuan","Liu, Hongtao","Wang, Jizhou","Yao, Ziqin","Zhang, Shengyu","Zhao, Desheng","Nashan, Bjorn","Shen, Aizong","Liu, Lianxin","Li, Lei"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277555","week":"202015|Apr 06 - Apr 12","doi":"10.1111/ajt.15897","source":"PubMed","locations":["Wuhan","China","ciclosporin"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"e_drugs":["Cyclosporine","lopinavir-ritonavir drug combination"],"_version_":1663798882943893506,"score":7.9164424,"similar":[{"pmid":32181990,"title":"Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.","text":["Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.","The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia.","Am J Transplant","Zhu, Lan","Xu, Xizhen","Ma, Ke","Yang, Junling","Guan, Hanxiong","Chen, Song","Chen, Zhishui","Chen, Gang","32181990"],"abstract":["The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia."],"journal":"Am J Transplant","authors":["Zhu, Lan","Xu, Xizhen","Ma, Ke","Yang, Junling","Guan, Hanxiong","Chen, Song","Chen, Zhishui","Chen, Gang"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32181990","week":"202012|Mar 16 - Mar 22","doi":"10.1111/ajt.15869","keywords":["COVID-19","coronavirus","immunosuppression","pneumonia","renal transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"e_drugs":["Methylprednisolone"],"_version_":1663352133831884801,"score":334.501},{"pmid":32243697,"title":"COVID-19 in post-transplantation patients- report of two cases.","text":["COVID-19 in post-transplantation patients- report of two cases.","Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here, two cases of COVID-19 infection in a post-transplant setting. First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome.","Am J Transplant","Huang, Jiaofeng","Lin, Heng","Wu, Yinlian","Fang, Yingying","Kumar, Rahul","Chen, Gongping","Lin, Su","32243697"],"abstract":["Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here, two cases of COVID-19 infection in a post-transplant setting. First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome."],"journal":"Am J Transplant","authors":["Huang, Jiaofeng","Lin, Heng","Wu, Yinlian","Fang, Yingying","Kumar, Rahul","Chen, Gongping","Lin, Su"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243697","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15896","keywords":["COVID-19","Coronavirus","transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"e_drugs":["Methylprednisolone"],"_version_":1663352135757070338,"score":293.8304},{"pmid":32243672,"title":"SARS Cov2 infection in a renal transplanted patients. A case report.","text":["SARS Cov2 infection in a renal transplanted patients. A case report.","The clinical manifestation of COVID-19 can vary from an asymptomatic course to ARDS requiring invasive mechanical ventilation and extracorporeal membrane oxygenation. A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression. It is possible that Immunosuppression can \"be protective\" as the cytokine storm is an important factor in the disease story. Despite the good outcome reported in the present case report, is remains of vital importance the solid organ transplant patients use precautions in order to avoid the infection.","Am J Transplant","Seminari, Elena","Colaneri, Marta","Sambo, Margherita","Gallazzi, Ilaria","Di Matteo, Angela","Silvia, Roda","Bruno, Raffaele","32243672"],"abstract":["The clinical manifestation of COVID-19 can vary from an asymptomatic course to ARDS requiring invasive mechanical ventilation and extracorporeal membrane oxygenation. A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression. It is possible that Immunosuppression can \"be protective\" as the cytokine storm is an important factor in the disease story. Despite the good outcome reported in the present case report, is remains of vital importance the solid organ transplant patients use precautions in order to avoid the infection."],"journal":"Am J Transplant","authors":["Seminari, Elena","Colaneri, Marta","Sambo, Margherita","Gallazzi, Ilaria","Di Matteo, Angela","Silvia, Roda","Bruno, Raffaele"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243672","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15902","source":"PubMed","locations":["Cov2"],"topics":["Case Report"],"weight":1,"_version_":1663352135807401984,"score":272.00922},{"pmid":32279418,"title":"Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).","text":["Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).","During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case-report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy.","Transpl Infect Dis","Bartiromo, Marilu","Borchi, Beatrice","Botta, Annarita","Bagala, Alfredo","Lugli, Gianmarco","Tilli, Marta","Cavallo, Annalisa","Xhaferi, Brunilda","Cutruzzula, Roberta","Vaglio, Augusto","Bresci, Silvia","Larti, Aida","Bartoloni, Alessandro","Cirami, Calogero","32279418"],"abstract":["During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case-report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy."],"journal":"Transpl Infect Dis","authors":["Bartiromo, Marilu","Borchi, Beatrice","Botta, Annarita","Bagala, Alfredo","Lugli, Gianmarco","Tilli, Marta","Cavallo, Annalisa","Xhaferi, Brunilda","Cutruzzula, Roberta","Vaglio, Augusto","Bresci, Silvia","Larti, Aida","Bartoloni, Alessandro","Cirami, Calogero"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279418","week":"202016|Apr 13 - Apr 19","doi":"10.1111/tid.13286","keywords":["COVID-19","drug-drug interaction","kidney transplant"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663890921989603328,"score":269.1032},{"pmid":32198834,"title":"Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?","text":["Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?","COVID-19 is novel infectious disease with an evolving understanding of its epidemiology and clinical manifestations. Immunocompromised patients often present atypical presentations of viral diseases. Herein we report a case of a COVID-19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48h. In these high risk populations, protocols for screening for SARS-Cov2 may be needed to be re-evaluated.","Am J Transplant","Guillen, Elena","Pineiro, Gaston Julio","Revuelta, Ignacio","Rodriguez, Diana","Bodro, Marta","Moreno, Asuncion","Campistol, Josep M","Diekmann, Fritz","Ventura-Aguiar, Pedro","32198834"],"abstract":["COVID-19 is novel infectious disease with an evolving understanding of its epidemiology and clinical manifestations. Immunocompromised patients often present atypical presentations of viral diseases. Herein we report a case of a COVID-19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48h. In these high risk populations, protocols for screening for SARS-Cov2 may be needed to be re-evaluated."],"journal":"Am J Transplant","authors":["Guillen, Elena","Pineiro, Gaston Julio","Revuelta, Ignacio","Rodriguez, Diana","Bodro, Marta","Moreno, Asuncion","Campistol, Josep M","Diekmann, Fritz","Ventura-Aguiar, Pedro"],"date":"2020-03-22T11:00:00Z","year":2020,"_id":"32198834","week":"202012|Mar 16 - Mar 22","doi":"10.1111/ajt.15874","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663352133588615169,"score":261.37463}]}